AU2002246228A1 - Treatment and prevention of sexual dysfunction resulting from ssri-therapy by using a tetrahydrobenz cd indole-6-carboxamide - Google Patents

Treatment and prevention of sexual dysfunction resulting from ssri-therapy by using a tetrahydrobenz cd indole-6-carboxamide

Info

Publication number: AU2002246228A1
Authority: AU; Australia
Prior art keywords: tetrahydrobenz; ssri; carboxamide; indole; therapy
Prior art date: 2001-03-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002246228A

Other languages

English (en)

Inventor

John Blundell Hutchison

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ligand UK Research Ltd

Original Assignee

Vernalis Research Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-15

Filing date

2002-03-15

Publication date

2002-10-03

2002-03-15 Application filed by Vernalis Research Ltd filed Critical Vernalis Research Ltd

2002-10-03 Publication of AU2002246228A1 publication Critical patent/AU2002246228A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Gynecology & Obstetrics (AREA)
Indole Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU2002246228A 2001-03-15 2002-03-15 Treatment and prevention of sexual dysfunction resulting from ssri-therapy by using a tetrahydrobenz cd indole-6-carboxamide Abandoned AU2002246228A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB0106446.8A GB0106446D0 (en)	2001-03-15	2001-03-15	Chemical compounds
GB0106446.8		2001-03-15
PCT/GB2002/001220 WO2002074288A2 (fr)	2001-03-15	2002-03-15	Composés chimiques

Publications (1)

Publication Number	Publication Date
AU2002246228A1 true AU2002246228A1 (en)	2002-10-03

Family

ID=9910774

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002246228A Abandoned AU2002246228A1 (en)	2001-03-15	2002-03-15	Treatment and prevention of sexual dysfunction resulting from ssri-therapy by using a tetrahydrobenz cd indole-6-carboxamide

Country Status (3)

Country	Link
AU (1)	AU2002246228A1 (fr)
GB (1)	GB0106446D0 (fr)
WO (1)	WO2002074288A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US10675280B2 (en)	2001-10-20	2020-06-09	Sprout Pharmaceuticals, Inc.	Treating sexual desire disorders with flibanserin
UA78974C2 (en)	2001-10-20	2007-05-10	Boehringer Ingelheim Pharma	Use of flibanserin for treating disorders of sexual desire
WO2005007166A1 (fr) *	2003-07-16	2005-01-27	Pfizer Limited	Traitement des dysfonctionnements sexuels
US7649002B2 (en)	2004-02-04	2010-01-19	Pfizer Inc	(3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
PL1912650T3 (pl)	2005-08-03	2018-01-31	Sprout Pharmaceuticals Inc	Zastosowanie flibanseryny w leczeniu otyłości
EP2037927B1 (fr)	2006-06-30	2010-01-27	Boehringer Ingelheim International GmbH	Flibansérine dans le traitement de l'incontinence urinaire et des maladies associées
CL2008002693A1 (es)	2007-09-12	2009-10-16	Boehringer Ingelheim Int	Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad
CA2686480A1 (fr)	2008-12-15	2010-06-15	Boehringer Ingelheim International Gmbh	Nouveaux sels

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CZ285762B6 (cs) *	1993-06-10	1999-11-17	Eli Lilly And Company	Farmaceutický prostředek vhodný pro prevenci dávení a zvracení a pro ošetřování sexuální dysfunkce savců a jeho použití

2001
- 2001-03-15 GB GBGB0106446.8A patent/GB0106446D0/en not_active Ceased
2002
- 2002-03-15 AU AU2002246228A patent/AU2002246228A1/en not_active Abandoned
- 2002-03-15 WO PCT/GB2002/001220 patent/WO2002074288A2/fr not_active Ceased

Also Published As

Publication number	Publication date
GB0106446D0 (en)	2001-05-02
WO2002074288A2 (fr)	2002-09-26
WO2002074288A3 (fr)	2003-02-27

Similar Documents

Publication	Publication Date	Title
WO2001078781A8 (fr)	2002-06-27	Procedes de prevention et de traitement des troubles gastro-intestinaux
AU2002250250A1 (en)	2002-09-19	Intravascular device for treatment of hypertension
AU2003219934A1 (en)	2003-09-22	Method of treatment or prevention of obesity
AU2002257936A1 (en)	2002-12-03	Methods of well treatment
AU2003290548A1 (en)	2004-06-07	Prevention and treatment of synucleinopathic disease
AU2001250821A1 (en)	2001-09-24	Methods and compositions for the treatment and prevention of erectile dysfunction
AU2003219981A1 (en)	2003-09-22	Benzimidazole-derivatives for the treatment of sexual dysfunction
AU2002237667A1 (en)	2002-05-27	Methods for the treatment and prevention of urinary stone disease
AU2003274476A1 (en)	2004-06-07	Treatment of female sexual dysfunction
AU2002246228A1 (en)	2002-10-03	Treatment and prevention of sexual dysfunction resulting from ssri-therapy by using a tetrahydrobenz cd indole-6-carboxamide
AU2003263760A1 (en)	2004-01-19	Methods for the treatment or prevention of obesity
AU2001278981A1 (en)	2002-02-05	Prevention and treatment of sexual arousal disorders
AU2002360555A1 (en)	2003-06-23	Treatment of genitourinary tract disorders
AU2001271887A1 (en)	2002-01-21	Methods for diagnosis and treatment of psychiatric disorders
AU3894600A (en)	2000-10-09	Method of treating sexual dysfunction
AU5908300A (en)	2001-01-22	Prevention and treatment of amyloid-associated disorders
AU2001269785A1 (en)	2001-12-17	Method of treatment of obesity and paralyzed muscle and ergogenic aids
AU7652400A (en)	2001-04-17	Novel combination for the treatment of sexual dysfunction
AU2003278084A1 (en)	2004-05-04	Benzo(d)azepine derivatives for the treatment of neurological and psychiatric disorders
PL362980A1 (en)	2004-11-02	Treatment of sexual dysfunction
AU8906201A (en)	2002-03-26	Methods and compositions for the treatment and prevention of sexual dysfunction
AU2002222125A1 (en)	2002-06-18	Prevention and treatment of tachyphylactic response
AU4034800A (en)	2001-04-23	Novel compositions and methods for prevention and treatment of protozoal disease
AU2001253560A1 (en)	2001-10-30	Methods of treatment
AU2002315366A1 (en)	2003-01-02	Therapeutic treatment for sexual dysfunction

Legal Events

Date	Code	Title	Description
2004-02-12	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase